With 18.50% CAGR, Cell and Gene Therapy Consumables Market Size Worth USD 17427.85 Million by 2028: Comprehensive Research Report by Facts & Factors

[216+ Pages Report] According to Facts and Factors, the demand analysis of Global Cell and Gene Therapy Consumables Market size & share revenue is estimated to grow about USD 17427.85 million by 2028, at a CAGR of approximately 18.50% between 2022 and 2028. The key market players are listed in the report with their sales, revenues and strategies are Novartis AG, Amgen, Merck, Gilead Sciences, Bristol-Myers Squibb, Organogenesis Holdings, Dendreon, Vericel, Bluebird Bio, Fibrocell Science and others.

NEW YORK, United States, Aug. 23, 2022 (GLOBE NEWSWIRE) -- According to Facts and Factors has published a new research report titled “Cell and Gene Therapy Consumables Market Size, Share, Growth Analysis Report By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Dermatology, Musculoskeletal, Others), By Fleet Type (Commercial Fleet, Non-Commercial Fleet ), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” in its research database.

“According to the latest research study, the demand of global Cell and Gene Therapy Consumables Market size & share in terms of revenuewas valued at USD 6,294.10 million in 2021 and it is expected to surpass around USD 17427.85 million mark by 2028, growing at a compound annual growth rate (CAGR) of approximately 18.50% during the forecast period 2022 to 2028.”

What are Cell and Gene Therapy Consumables? How big is the Cell and Gene Therapy Consumables Industry?

Report Overview:

Cell and gene therapy (CGT) is a quickly developing discipline developing potential new treatments for genetic and cancerous disorders and moving into autoimmune, cardiovascular, musculoskeletal, and many other ailments. Researchers, patient organizations, and regulators have shown great interest and hope in the cell and gene therapy sector, which has resulted in significant R&D investment. Numerous governments and regulatory agencies have developed policies and patent settings to promote cell and gene therapy growth. There is a sense of urgency in the pharma/biofield to create cell and gene therapies because they frequently target areas of uncommon and underserved diseases for which there are few other treatments available.

The number of cell and gene therapy products being reviewed in the early stages of development has increased, according to the U.S. Food and Drug Administration (FDA). The increased number of investigational new drug (IND) applications can serve as additional proof. Several medication developers prefer to rely on third-party service providers to deliver raw materials, such as cell culture medium, cell isolation kits, and cell separation reagents, to generate high-quality cellular and gene treatments. Over 60 service providers supply raw materials and consumables to develop cell and gene therapies.

Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.fnfresearch.com/sample/cell-and-gene-therapy-consumables-market

(A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
About 216+ Pages Research Report (Including Recent Research)
Provide detailed chapter-by-chapter guidance on Request
Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
Includes Tables and figures have been updated
The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
Facts and Factors research methodology

(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)

Market Dynamics

The market will grow during the period as knowledge of gene and cell therapies increases. However, randomized control tests will prevent the market from growing throughout the predicted time frame. However, the rising popularity of using cell and gene therapy to treat neurodegenerative diseases will fuel market expansion in the upcoming years. Due to the rising prevalence of chronic illnesses like cancer and heart conditions, the market is expected to grow during forecasting. In addition, an increase in the prevalence of these conditions generates a profitable market need for improved therapeutics, which will peak throughout the projection period.

The market is expanding due to the rise in the prevalence of genetic illnesses like cystic fibrosis and sickle cell anemia, as well as the increase in funding for research and development of cell and gene therapies. The strategic moves made by market participants and the increase in spending in the healthcare sector are two additional variables projected to fuel the expansion of the global cell and gene therapy consumables market. It supports the expansion of the cell and gene therapy consumables market.

Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/cell-and-gene-therapy-consumables-market

Cell and Gene Therapy Consumables Market: COVID-19 Impact Analysis

As a result of the majority of research being focused on treating and diagnosing COVID-19, the number of clinical trials for cell and gene therapy declined in the early 2020s. This had an effect on the market for consumables used in cell and gene therapy. On the other side, the COVID-19 challenge served to stimulate innovative thinking. Some CGTs are making more progress in gene therapy because they are working together to make RNA-based COVID-19 vaccines. This is helping the cell and gene therapy consumables industry grow.

Segmentation Analysis

The global cell and gene therapy consumables market is segregated based on deployment, component, fleet type, and region. Based on product, the market is segregated into cell and gene therapy. In 2021, the gene therapy segment dominated the global cell and gene therapy consumables. Based on the application, the market is segregated into oncology, dermatology, musculoskeletal and others. In 2021, the dermatology category dominated the global cell and gene therapy consumables. Based on the end-user, the market is segmented into hospitals, ambulatory surgical centers, cancer care centers, wound care centers and others. In 2021, the hospital's segment dominated the global cell and gene therapy consumables.

The global Cell and Gene Therapy Consumables market is segmented as follows:

By Product

Cell Therapy
Gene Therapy

By Application

Oncology
Dermatology
Musculoskeletal
Others

By Fleet Type

Commercial Fleet
Non-Commercial Fleet

Browse the full “Cell and Gene Therapy Consumables Market Size, Share, Growth Analysis Report - Global and Regional Industry Insights, Overview, Emerging Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” Report at https://www.fnfresearch.com/cell-and-gene-therapy-consumables-market

Competitive Landscape

Some of the main competitors dominating the global Cell and Gene Therapy Consumables market include -

Novartis AG
Amgen
Merck
Gilead Sciences
Bristol-Myers Squibb
Organogenesis Holdings
Dendreon
Vericel
Bluebird Bio
Fibrocell Science

Key Insights from Primary Research:

According to the analysis shared by our research forecaster, the Cell and Gene Therapy Consumables market is likely to expand at a CAGR of around 18.50% during the forecast period (2022-2028).
In terms of revenue, the Cell and Gene Therapy Consumables market size was valued at around US$ 6,294.10 million in 2021 and is projected to reach US$ 17427.85 million by 2028.
In terms of product, gene therapy will be the most important segment of cell and gene therapy consumables in the world in 2021.
In 2021, the dermatology segment led the global cell and gene therapy consumables market by application segment.
The prevalence of genetic illnesses in the region made North America the most lucrative market for cell and gene therapy consumables in 2021.

Have Any Query? Ask Our Experts: https://www.fnfresearch.com/inquiry/cell-and-gene-therapy-consumables-market

Key questions answered in this report:

What is the market size and growth rate forecast for Cell and Gene Therapy Consumables industry?
What are the main driving factors propelling the Cell and Gene Therapy Consumables Market forward?
What are the leading companies in the Cell and Gene Therapy Consumables Industry?
What segments does the Cell and Gene Therapy Consumables Market cover?
How can I receive a free copy of the Cell and Gene Therapy Consumables Market sample report and company profiles?

Key Offerings:

Market Size & Forecast by Revenue | 2022−2028
Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
Market Segmentation – A detailed analysis by Product, Application, Fleet Type, and Region
Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/cell-and-gene-therapy-consumables-market

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Regional Analysis:

The global cell and gene therapy consumables market is divided into geographic regions: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America dominated the global market for cell and gene therapy consumables in 2021. Due to the widespread presence of genetic diseases. In the U.S., 135 million new cases of Parkinson's disease and traumatic brain injuries are reported yearly.

Around 1.2 million adults are diagnosed with early symptoms of brain illnesses each year, of which Alzheimer's disease causes 21%. The need for cell and gene therapy is also anticipated to rise with increased research and development activity. The expansion of cell and gene therapy consumables in the U.S. is being driven by the regulatory approval process, which is developing and becoming more beneficial for vendors creating goods for cell and gene therapy.

By Region

North America
- U.S.
- Canada
- Rest of North America
Europe
- France
- UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America

Report Scope

Report Attribute	Details
Market Size in 2021	USD 6,294.10 Million
Projected Market Size in 2028	USD 17427.85 Million
CAGR Growth Rate	18.50% CAGR
Base Year	2021
Forecast Years	2022-2028
Key Market Players	Novartis AG, Amgen, Merck, Gilead Sciences, Bristol-Myers Squibb, Organogenesis Holdings, Dendreon, Vericel, Bluebird Bio, Fibrocell Science, and Others
Key Segment	By Product, Application, Fleet Type, and Region
Major Regions Covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Purchase Options	Request customized purchase options to meet your research needs.

Request For Free Sample Report of the Global Cell and Gene Therapy Consumables Market @ https://www.fnfresearch.com/sample/cell-and-gene-therapy-consumables-market

Browse Other Related Research Reports from Facts & Factors:

Childcare Management Software Market Size: https://www.fnfresearch.com/childcare-management-software-market

Oxygen Therapy Market Size: https://www.fnfresearch.com/oxygen-therapy-market

Gene Therapy Market Size: https://www.fnfresearch.com/gene-therapy-market

Mesotherapy Market Size: https://www.fnfresearch.com/mesotherapy-market

Inhalation Therapy Nebulizer Market Size: https://www.fnfresearch.com/inhalation-therapy-nebulizer-market-by-product-pneumatic-nebulizers-1292

Plasma Therapy Market Size: https://www.fnfresearch.com/plasma-therapy-market-type-pure-prp-leucocyte-rich-1279

About Facts & Factors:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us on LinkedIn: https://www.linkedin.com/company/fnfresearch

Follow Us on Twitter: https://twitter.com/fnfresearch

Follow Us on Facebook: https://www.facebook.com/factsandfactors/

Contact Us:

Rushikesh Dorge

USA: +1 347 690-0211

United Kingdom: +44 2032 894158

Japan: +81 50 5806 9039

India: +91 73877 19999

Email: sales@fnfresearch.com

Web: https://www.fnfresearch.com

Blog: http://fnfnewsblog.com